Barts Health NHS Trust selects Hyland’s ECM solution
OnBase is expected to reduce the cost and physical space required for storing paper patient records and to provide the workflow to streamline document-based processes. Bart’s Health NHS
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.